Ticker Details
Abeona Therapeutics Inc. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
IPO Date:	November 9, 1984
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$285.05M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 3.54%
Avg Daily Range (30 D):	$0.11 | 2.12%
Avg Daily Range (90 D):	$0.12 | 2.40%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	1.08M
Avg Daily Volume (90 D):	1.46M

Trade Size
Avg Trade Size (Sh.):	79
Avg Trade Size (Sh.) (30 D):	126
Avg Trade Size (Sh.) (90 D):	139

Institutional Trades
Total Institutional Trades:	408
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$.61M
Avg Institutional Trade (90 D):	$2.13M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.74M
Avg Closing Trade (30 D):	$.65M
Avg Closing Trade (90 D):	$.83M
Avg Closing Volume:	48.28K

News

Dec 31, 2025 @ 12:30 PM Abeona Therapeutics® Announces New Employee Ind... Source: Na

Nov 12, 2025 @ 4:37 PM Here's Why Abeona Therapeutics Popped Higher Today... Source: Lee Samaha

Sep 2, 2025 @ 8:59 AM Trends & Growth Strategies in the $13.5 Billion Ca... Source: Researchandmarkets.Com

Aug 12, 2025 @ 2:00 PM AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 ... Source: Dea Belazi

May 14, 2025 @ 5:57 PM US FDA Orphan Drug Rare Disease Market Clinical Tr... Source: Kuick Research

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.1	$2.07	$-.24
Diluted EPS	$-.1	$1.71	$-.24
Revenue	$M	$.4M	$M
Gross Profit
Net Income / Loss	$-5.16M	$108.83M	$-12.03M
Operating Income / Loss	$-24.02M	$-22.79M	$-19.73M
Cost of Revenue
Net Cash Flow	$-80.65M	$147.6M	$-7.42M
PE Ratio

Splits
Jul 05, 2022	1:25
Oct 24, 2014	1:50
Jun 05, 2006	1:5